JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOELLE, G. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KOELLE, G. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 88, Issue 3, 232-237, 1946
Copyright © 1946 by American Society for Pharmacology and Experimental Therapeutics


PROTECTION OF CHOLINESTERASE AGAINST IRREVERSIBLE INACTIVATION BY DI-ISOPROPYL FLUOROPHOSPHATE IN VITRO

GEORGE B. KOELLE 1

1 Pharmacology Section, Medical Division, Edgewood Arsenal, Maryland

1. Eserine, by combining reversibly with rat brain cholinesterase, has been shown to protect the enzyme against irreversible inactivation by DFP in vitro. The degree of protection varied directly with the concentration of eserine used. It is concluded that this phenomenon might explain the mechanism by which prophylactic eserine protects cats against DFP poisoning in vivo.

2. Of nineteen other anticholinesterase drugs similarly tested, two showed marked protection (prostigmin and carbamylcholine), six afforded relatively slight protection (pilocarpine, nicotine, atropine, choline, procaine and morphine) and eleven showed none (methylene blue, strychnine, atabrine, quinine, sodium fluoride, thiamin, cysteine, sodium p-amino-benzoate, acetyl-beta-methylcholine, acetyicholine and Intocostrin). The protective property does not appear to depend on the potency of anticholinesterase activity alone, but also on the ability of a compound to compete with DFP for a specific active group of the cholinesterase molecule.

Submitted on July 5, 1946







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1946 by the American Society for Pharmacology and Experimental Therapeutics.